SEARCH

SEARCH BY CITATION

REFERENCES

  • Abbs S, Bobrow M. 1992. Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J Med Genet 29:191196.
  • Albertson DG, Pinkel D. 2003. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12 Spec No 2:R145152.
  • Armour JA, Sismani C, Patsalis PC, Cross G. 2000. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res 28:605609.
  • Beggs AH, Koenig M, Boyce FM, Kunkel LM. 1990. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86:4548.
  • Campbell KP, Kahl SD. 1989. Association of dystrophin and an integral membrane glycoprotein. Nature 338:259262.
  • Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. 1988. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:1114111156.
  • den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, van Broeckhoven C, Pearson PL, van Ommen GJ. 1989. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835847.
  • Dhami P, Coffey AJ, Abbs S, Vermeesch JR, Dumanski JP, Woodward KJ, Andrews RM, Langford C, Vetrie D. 2005. Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome. Am J Hum Genet 76:750762.
  • Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315319.
  • Gardner RJ, Bobrow M, Roberts RG. 1995. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet 57:311320.
  • Grimm T. 1984. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations. Am J Med Genet 18:719723.
  • Hoffman EP, Brown Jr RH, Kunkel LM. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919928.
  • Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, Lupsky W, Chamberlain J, Caskey Y, Shapiro F, Kunkel LM. 1988. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 318:13631368.
  • Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG. 1990. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotype-genotype correlation. Am J Hum Genet 46:682695.
  • Inoue K, Osaka H, Thurston VC, Clarke JT, Yoneyama A, Rosenbarker L, Bird TD, Hodes ME, Shaffer LG, Lupski JR. 2002. Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71:838853.
  • Klamut HJ, Gangopadhyay SB, Worton RG, Ray PN. 1990. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol 10:193205.
  • Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509517.
  • Lee JA, Inoue K, Cheung SW, Shaw CA, Stankiewicz P, Lupski JR. 2006. Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease. Hum Mol Genet 15:22502265.
  • Lee JA, Carvalho CMB, Lupski JR. 2007. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:12351247.
  • Lipson D, Aumann Y, Ben-Dor A, Linial N, Yakhini Z. 2006. Efficient calculation of interval scores for DNA copy number data analysis. J Comput Biol 13:215228.
  • Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, Olshen A, Venkatraman E, Norton L, Wigler M. 2003. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 13:22912305.
  • Moser H. 1984. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 66:1740.
  • Nobile C, Galvagni F, Marchi J, Roberts R, Vitiello L. 1995. Genomic organization of the human dystrophin gene across the major deletion hot spot and the 3′ region. Genomics 28:97100.
  • Oudet C, Hanauer A, Clemens P, Caskey T, Mandel JL. 1992. Two hot spots of recombination in the DMD gene correlate with the deletion prone regions. Hum Mol Genet 1:599603.
  • Padiath QS, Saigoh K, Schiffmann R, Asahara H, Yamada T, Koeppen A, Hogan K, Ptacek LJ, Fu YH. 2006. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38:11141123.
  • Pinto D, Marshall C, Feuk L, Scherer SW. 2007. Copy-number variation in control population cohorts. Hum Mol Genet 16 Spec No. 2:R168173.
  • Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, Gonzalez JR, Gratacos M, Huang J, Kalaitzopoulos D, Komura D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW, Hurles ME. 2006. Global variation in copy number in the human genome. Nature 444:444454.
  • Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57.
  • Sellner LN, Taylor GR. 2004. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 23:413419.
  • Shaw CJ, Lupski JR. 2005. Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms. Hum Genet 116:17.
  • Staaf J, Torngren T, Rambech E, Johansson U, Persson C, Sellberg G, Tellhed L, Nilbert M, Borg A. 2008. Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH). Hum Mutat 29:555564.
  • Stankiewicz P, Shaw CJ, Dapper JD, Wakui K, Shaffer LG, Withers M, Elizondo L, Park SS, Lupski JR. 2003. Genome architecture catalyzes nonrecurrent chromosomal rearrangements. Am J Hum Genet 72:11011116.
  • Toffolatti L, Cardazzo B, Nobile C, Danieli GA, Gualandi F, Muntoni F, Abbs S, Zanetti P, Angelini C, Ferlini A, Fanin M, Patarnello T. 2002. Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene. Genomics 80:523530.
  • Tuffery S, Lenk U, Roberts RG, Coubes C, Demaille J, Claustres M. 1995. Protein truncation test: analysis of two novel point mutations at the carboxy-terminus of the human dystrophin gene associated with mental retardation. Hum Mutat 6:126135.
  • Tuffery-Giraud S, Chambert S, Demaille J, Claustres M. 1999. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects. Hum Mutat 14:359368.
  • Watkins SC, Hoffman EP, Slayter HS, Kunkel LM. 1988. Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333:863866.
  • White S, Kalf M, Liu Q, Villerius M, Engelsma D, Kriek M, Vollebregt E, Bakker B, van Ommen GJ, Breuning MH, den Dunnen JT. 2002. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet 71:365374.
  • White SJ, Sterrenburg E, van Ommen GJ, den Dunnen JT, Breuning MH. 2003. An alternative to FISH: detecting deletion and duplication carriers within 24 hours. J Med Genet 40:e113.
  • Worton RG, Thompson MW. 1988. Genetics of Duchenne muscular dystrophy. Annu Rev Genet 22:601629.